Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation - Chiou, Wei-Ru; Lin, Po-Lin; Huang, Chun-Che; Chuang, Jen-Yu; Liu, Lawrence Yu-Min; Su, Min-I; Liao, Feng-Ching; Kuo, Jen-Yuan; Tsai, Cheng-Ting; Wu, Yih-Jer; Wang, Kuang-Te; Lee, Ying-Hsiang (Scientific reports, 2022)
Keywords: 692/4019; 692/4019/592; 692/4019/592/75; 692/4019/592/75/29; 692/4019/592/75/29/1309; Ablation; Anti-Arrhythmia Agents - adverse effects; Anticoagulants; Arrhythmia; Atrial Fibrillation - complications; Atrial Fibrillation - drug therapy; Cardiac arrhythmia; Catheter Ablation - adverse effects; Catheters; Congestive heart failure; Fibrillation; Heart failure; Heart Failure - drug therapy; Heart rate; Humanities and Social Sciences; Humans; Medical instruments; multidisciplinary; Multivariate analysis; Patients; Radiofrequency ablation; Retrospective Studies; Rivaroxaban - adverse effects; Science; Science (multidisciplinary); Stroke; Stroke - epidemiology; Stroke - etiology; Stroke - prevention & control; Thromboembolism; Thromboembolism - etiology; Treatment Outcome